Weil Company’s Diebold Nixdorf Incorporated DBD Stock Holding History

Weil Company’s Portfolio DBD Stock Details DBD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-1,150	Closed	-$13K	–	363
2019 Q3	$13K	Buy	+1,150	New	+$13.6K	0.01%	269

Other funds holding DBD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Sapience Investments Newport Beach, California $772K AUM 24.07% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Weil Company's DBD Position: Q4 2019 in Review

Weil Company sold out of Diebold Nixdorf Incorporated (DBD) in Q4 2019, closing a stake of 1,150 shares — an estimated $13K sold.

Weil Company first reported a position in DBD in Q3 2019 and held it in 1 quarter. The position peaked at $13K in Q3 2019. 199 funds tracked by Wall St. Rank hold DBD as of Q4 2019.

Weil Company reported no remaining Diebold Nixdorf Incorporated position as of Q4 2019 after selling out during the quarter.
Weil Company sold 1,150 Diebold Nixdorf Incorporated shares in Q4 2019, an estimated $13K.
Weil Company first reported a position in Diebold Nixdorf Incorporated in Q3 2019 and held it in 1 quarter.
Weil Company's Diebold Nixdorf Incorporated position peaked at $13K in Q3 2019.
199 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q4 2019.

Based on Weil Company's 13F filing for Q4 2019, filed 13 Feb 2020.